[ RECIPIENT ENTITY RECORD ]

Karuna Therapeutics

VERIFIED NODE ID: 001381 · karuna-therapeutics
R TARGET NODE — CAPITAL RECIPIENT
Karuna Therapeutics
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Karuna Therapeutics
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Karuna Therapeutics is a biopharmaceutical company dedicated to developing transformative medicines for people living with psychiatric and neurological conditions. Based in Massachusetts, the firm focuses on novel therapies for schizophrenia. It is a significant recipient of institutional healthcare capital through large-scale biotech acquisitions.

Capital Influx Log (Transactions)
Date Type Amount
19 May 2026 EQUITY $14.0B